 A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes. After successful screening the subjects will be randomized into one of two groups: a CSII group alone and a CSII group Real Time Sensor Augmentation group RTSA group. The CSII group will serve as the control for the CSIIRTSA group. The trial will last for one year. 